Business
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors First Brazilian Obesity Medicine Symposium
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors First Brazilian Obesity Medicine Symposium.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n SAN DIEGO, CA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil is sponsoring the Brazilian Society of Obesity Medicine’s first Obesity Medicine Symposium on March 3-6, 2022. The symposium, which will take place at the Centro South Convention Center in Santa Catarina, is designed to unite educators, wellness organizations, and medical professionals to discuss new techniques and technological advancements in obesity medicine. HempMeds® Brasil chose to sponsor and present at this event to educate people on how cannabidiol (CBD) plays a vital role in our daily wellness routines.   \"This is a great opportunity for us to educate people on what CBD is, its potential wellness benefits, and the current research that is being conducted on how CBD can be used by people around the world,\" said HempMeds® Brasil Managing Director Matheus Patelli. \"CBD can be legally imported in Brazil and is subsidized by the Brazilian government for many indications so that people should understand how and why they should be taking it.” In addition to sponsoring the event, HempMeds® Brasil will be hosting a presentation at the symposium on March 4 about medical cannabis and CBD including the variety of products that exist in Brazil, wellness applications, and legality and safety information. “We have experienced exceptional operational and revenue growth in Brazil over the past few years and our invitation to sponsor this event is a testament to our strong brand presence there,” said Medical Marijuana, Inc. CEO Blake Schroeder. “In partnership with some of Brazil’s most prestigious doctors and researchers, we have created long-lasting relationships with Brazilian consumers based upon transparency, education, and trust.” To learn more about HempMeds® Brasil, please visit www.hempmeds.com.br. About HempMeds® Brasil HempMeds® Brasil was the first company to receive approval from the National Sanitary Surveillance Agency (Anvisa) to import a product based on cannabidiol...